About this episode

Dr. Richard DiMarchi discusses the evolution of GLP-1 science and future obesity treatments.

In this episode of The GLP-1 Podcast Show, I speak with Dr. Richard DiMarchi, Distinguished Professor at Indiana University and a pioneer in peptide therapeutics, about the scientific journey behind GLP-1 therapies, multiagonist drug development, and future obesity treatments. We explore glucagon, GIP, triple agonists, and emerging innovations shaping metabolic medicine. Listen now on all major platforms! "For decades, glucagon was viewed primarily as a hormone that raises blood glucose. Research later revealed that glucagon could also promote weight reduction and improve liver metabolism when balanced appropriately with GLP-1 activity." Meet the guest: Dr. Richard DiMarchi https://www.linkedin.com/in/richard-dimarchi-642a5710/ is a Distinguished Professor at Indiana University and a recognized leader in peptide therapeutics, diabetes research, and obesity medicine. His work contributed to major advances in insulin, glucagon, and multiagonist therapies, while also helping establish several biotechnology companies. Dr. DiMarchi continues to advance innovation in the treatment of metabolic diseases through research and translational science. Listen to Dr. Richard DiMarchi on The…

People in this episode

Guest: Dr. Richard DiMarchi

Topics covered

• GLP-1 science
• peptide therapeutics
• obesity treatments
• multiagonist design
• metabolic medicine

Keywords

• GLP-1
• peptide therapeutics
• obesity
• multiagonist
• metabolic diseases

Mentioned in this episode

Organizations: Indiana University, Wisenetix

Products: GLP-1 therapies, multiagonist drug development, triple agonists, insulin, glucagon, GIP, metabolic medicine

More episodes of The GLP-1 Podcast Show

• Dr. Ashley Koff: Weight Health in the GLP-1 Era | Ep. 13 · September 7, 2026 · 35 min
• Dr. Timothy Garvey: Adiposity-Based Chronic Disease Explained | Ep. 12 · August 24, 2026 · 34 min
• Dr. Christopher Kramer: Tirzepatide And Cardiovascular Health | Ep. 11 · August 3, 2026 · 33 min
• Dr. Sandra Christensen: Preserving Muscle During GLP-1 Treatment | Ep. 09 · June 1, 2026 · 30 min
• Dr. Jason Itri: GLP-1 Microdosing Strategy | Ep. 08 · May 4, 2026 · 33 min
• Dr. Catherine Toomer: GLP-1 Dosing Strategy | Ep. 07 · April 6, 2026 · 29 min

Explore listener stats, chart rankings, contacts and more on the The GLP-1 Podcast Show podcast page.